Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmented Renal Clearance in Neurocritical Care Population: A Prospective Multicenter Study

NCT07410624 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT07410624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07410624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmented Renal Clearance in Neurocritical Care Population: A Prospective Multicenter Study
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2021
Completion date
September 30, 2026
Enrollment
512 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

augmented renal clearance (arc), bacterial meningitis, intracerebral hemorrhage, ischemic stroke, status epilepticus, subarachnoid hemorrhage, aneurysmal, tbi (traumatic brain injury)